CA
RKDA icon

Clearstead Advisors’s Arcadia Biosciences RKDA Stock Holding History

Clearstead Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50
Closed -$4K – 1410
2021
Q3 		$4K Hold
50
– – ﹤0.01% 1056
2021
Q2 		$6K Buy
50
+25
+100% +$2.73K ﹤0.01% 864
2021
Q1 		$3K Hold
25
– – ﹤0.01% 933
2020
Q4 		$3K Hold
25
– – ﹤0.01% 857
2020
Q3 		$3K Hold
25
– – ﹤0.01% 794
2020
Q2 		$4K Hold
25
– – ﹤0.01% 690
2020
Q1 		$3K Buy
+25
New +$4.35K ﹤0.01% 690

Other funds holding RKDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Clearstead Advisors's RKDA Position: Q4 2021 in Review

Clearstead Advisors sold out of Arcadia Biosciences (RKDA) in Q4 2021, closing a stake of 50 shares — an estimated $4K sold.

Clearstead Advisors first reported a position in RKDA in Q1 2020 and held it in 7 quarters. The position peaked at $6K in Q2 2021. 27 funds tracked by Wall St. Rank hold RKDA as of Q4 2021.

  • Clearstead Advisors reported no remaining Arcadia Biosciences position as of Q4 2021 after selling out during the quarter.
  • Clearstead Advisors sold 50 Arcadia Biosciences shares in Q4 2021, an estimated $4K.
  • Clearstead Advisors first reported a position in Arcadia Biosciences in Q1 2020 and held it in 7 quarters.
  • Clearstead Advisors's Arcadia Biosciences position peaked at $6K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2021.

Based on Clearstead Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.